KLEO

Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications: Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs). They believe their technology represents a breakthrough in safer, more efficacious, and more convenient treatment options.

#People #Financial #Website #More

KLEO

Social Links:

Linkedin

Industry:

Health Care Medical Pharmaceutical

Founded:

2015-01-01

Address:

New Haven, Connecticut, United States

Country:

United States

Website Url:

http://www.kleopharmaceuticals.com

Total Employee:

11+

Status:

Closed

Contact:

(203)428-4596

Email Addresses:

[email protected]

Total Funding:

32 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Liquid Web

Current Advisors List

alex-goor_image

Alex Goor Board Member @ Kleo
Board_member

declan-doogan_image

Declan Doogan Board Chairman @ Kleo
Board_member

charles-drake_image

Charles Drake Board Member @ Kleo
Board_member

john-w-childs_image

John W. Childs Board Member @ Kleo
Board_member

Current Employees Featured

david-a-spiegel_image

David A. Spiegel
David A. Spiegel Founder @ Kleo
Founder

Founder

david-a-spiegel_image

David A. Spiegel

roy-prieb_image

Roy Prieb

Investors List

biohaven-pharmaceutical_image

Biohaven Pharmaceutical

Biohaven Pharmaceutical investment in Series B - Kleo

peptidream_image

Peptidream

Peptidream investment in Series B - Kleo

biohaven-pharmaceutical_image

Biohaven Pharmaceutical

Biohaven Pharmaceutical investment in Series A - Kleo

Official Site Inspections

http://www.kleopharmaceuticals.com

Host Informations
Whois Informations

Loading ...

More informations about "Kleo" on Search Engine